GB9827006D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9827006D0
GB9827006D0 GBGB9827006.9A GB9827006A GB9827006D0 GB 9827006 D0 GB9827006 D0 GB 9827006D0 GB 9827006 A GB9827006 A GB 9827006A GB 9827006 D0 GB9827006 D0 GB 9827006D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9827006.9A
Other versions
GB2344520A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phares Pharmaceutical Research NV
Original Assignee
Phares Pharmaceutical Research NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phares Pharmaceutical Research NV filed Critical Phares Pharmaceutical Research NV
Priority to GB9827006A priority Critical patent/GB2344520A/en
Publication of GB9827006D0 publication Critical patent/GB9827006D0/en
Priority to CA002352178A priority patent/CA2352178A1/en
Priority to PCT/GB1999/004070 priority patent/WO2000033817A1/en
Priority to AU17878/00A priority patent/AU1787800A/en
Priority to EP99961183A priority patent/EP1137402A1/en
Priority to JP2000586310A priority patent/JP2002532389A/en
Publication of GB2344520A publication Critical patent/GB2344520A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB9827006A 1998-12-08 1998-12-08 Pharmaceutical carriers comprising lipids and polymers Withdrawn GB2344520A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB9827006A GB2344520A (en) 1998-12-08 1998-12-08 Pharmaceutical carriers comprising lipids and polymers
CA002352178A CA2352178A1 (en) 1998-12-08 1999-12-08 Phospholipid compositions
PCT/GB1999/004070 WO2000033817A1 (en) 1998-12-08 1999-12-08 Phospholipid compositions
AU17878/00A AU1787800A (en) 1998-12-08 1999-12-08 Phospholipid compositions
EP99961183A EP1137402A1 (en) 1998-12-08 1999-12-08 Phospholipid compositions
JP2000586310A JP2002532389A (en) 1998-12-08 1999-12-08 Phospholipid composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9827006A GB2344520A (en) 1998-12-08 1998-12-08 Pharmaceutical carriers comprising lipids and polymers

Publications (2)

Publication Number Publication Date
GB9827006D0 true GB9827006D0 (en) 1999-02-03
GB2344520A GB2344520A (en) 2000-06-14

Family

ID=10843859

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9827006A Withdrawn GB2344520A (en) 1998-12-08 1998-12-08 Pharmaceutical carriers comprising lipids and polymers

Country Status (1)

Country Link
GB (1) GB2344520A (en)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
US5002940A (en) * 1984-11-06 1991-03-26 Ciba-Geigy Corporation Solid drug formulations and stable suspensions
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
FR2581541B1 (en) * 1985-05-09 1988-05-20 Rhone Poulenc Sante NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE EXTENDED RELEASE OF AN ACTIVE INGREDIENT AND THEIR PREPARATION METHOD
US4765978A (en) * 1986-12-16 1988-08-23 Schering Corporation Novel vaginal suppository
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
JPH0296516A (en) * 1988-09-29 1990-04-09 Dainippon Pharmaceut Co Ltd Granule and production thereof
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
SE9003100D0 (en) * 1990-09-28 1990-09-28 Kabivitrum Ab LIPID FORMULATION SYSTEM
JPH0525042A (en) * 1990-12-21 1993-02-02 Takeda Chem Ind Ltd Composition containing water-soluble vitamins
ES2202302T3 (en) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. MASSABLE COMPOSITION THAT FREE A PHARMACO.
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
DE4322826A1 (en) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmaceutical preparation
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions

Also Published As

Publication number Publication date
GB2344520A (en) 2000-06-14

Similar Documents

Publication Publication Date Title
HU9901606D0 (en) Pharmaceutical compositions
GB9827996D0 (en) Pharmaceutical Compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9727053D0 (en) Pharmaceutical compositions
PL343627A1 (en) Medicinal compositions
PT1466615E (en) Pharmaceutical composition
CY2569B1 (en) Pharmaceutical compositions
PL343769A1 (en) Pharmaceutical composition
GB9809213D0 (en) Pharmaceutical compositions
GB9818591D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
HK1044117B (en) Pharmaceutical composition
HK1030552A1 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9806487D0 (en) Pharmaceutical compositions
GB9921495D0 (en) Pharmaceutical compositions
HU9800078D0 (en) Pharmaceutical composition
GB9827006D0 (en) Pharmaceutical compositions
GB9827441D0 (en) Pharmaceutical compositions
GB9826822D0 (en) Pharmaceutical compositions
GB9814818D0 (en) Pharmaceutical compositions
GB9818953D0 (en) Pharmaceutical compositions
GB9826821D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)